Related Experiment Video
Updated: May 7, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
STAT5 fits the RISK profile for cardioprotection
Sean M Davidson1, Derek M Yellon
1The Hatter Cardiovascular Institute; University College London; London, UK.
A new, simple treatment may protect organs from damage caused by temporary blood flow loss, such as during heart attacks or strokes. Research is beginning to uncover how this safe, non-invasive method works.
Area of Science:
- Cardiovascular Science
- Translational Medicine
- Organ Protection
Background:
- Ischemia and reperfusion injury significantly impacts organs during events like heart attack and stroke.
- Current treatments for organ protection during these events are often invasive or have limitations.
- There is a critical need for simple, safe, and non-invasive organ-protective strategies.
Purpose of the Study:
- To introduce a novel, simple, cheap, safe, and non-invasive treatment for organ protection.
- To highlight preliminary research into the mechanism of this protective treatment.
- To discuss the potential application of this treatment in clinical scenarios involving temporary ischemia.
Main Methods:
- The abstract does not detail specific methods but refers to a recent publication by Heusch et al. in Circulation Research.
- The study likely involves investigating a newly discovered protective treatment.
- Further research is indicated to elucidate the underlying mechanisms.
Main Results:
- A simple, cheap, safe, and non-invasive treatment has been discovered that protects organs from ischemia and reperfusion injury.
- This treatment holds potential for protecting organs during critical events like heart attacks and strokes.
- Initial research has begun to explore the mechanism of this protective effect.
Conclusions:
- A promising new avenue for organ protection during ischemia and reperfusion has been identified.
- The discovered treatment offers a potentially revolutionary, non-invasive approach to managing critical cardiovascular and cerebrovascular events.
- Further research is essential to fully understand and optimize this protective strategy for clinical use.
Related Concept Videos
Relative Risk
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hazard Ratio
For example, in a clinical trial evaluating a...
Cardiomyopathy I: Introduction and Classification